News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ICON Announces Appointment of Professor William Hall to Board of Directors
February 22, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ICONplc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Professor William Hall as a non-executive director.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Immunology and inflammation
Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor
October 1, 2026
·
3 min read
·
Tristan Manalac
Insights
The race for access: How the FAIR Act could reclaim U.S. biotech leadership
October 1, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Manufacturing
BioNTech to close German manufacturing plants after failing to find buyers
September 30, 2026
·
2 min read
·
Nick Paul Taylor
Layoff Tracker
Novo, BioMarin, Enanta dole out pink slips
September 30, 2026
·
98 min read
·
BioSpace Editorial Staff
